BioCorRx (BICX) Cash & Equivalents (2010 - 2026)
BioCorRx (BICX) posted Cash & Equivalents of $211911.0 for Q1 2026, up 52.06% sequentially from $139360.0 in Q4 2025, and up 777.77% YoY from $24142.0 in Q1 2025.
BioCorRx (BICX) Cash & Equivalents (2010 - 2026) Analysis & Trends
BioCorRx has reported Cash & Equivalents for 17 years, with the latest figure at $211911.0 in Q1 2026.
- Quarterly Cash & Equivalents rose 777.77% year-over-year to $211911.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $211911.0 (up 777.77% YoY) and the FY2025 annual result came in at $139360.0, up 58.3% from the prior year.
- Cash & Equivalents improved to $211911.0 in Q1 2026 per BICX's latest filing, from $139360.0 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $287688.0 in Q3 2025 and troughed at $90.0 in Q3 2024.
- A 5-year average of $120702.0 and a median of $111461.0 in 2022 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents tumbled 99.94% in 2024, then jumped 319553.33% in 2025.
- Over 5 years, Cash & Equivalents stood at $68615.0 in 2022, then dropped by 4.94% to $65222.0 in 2023, then jumped by 34.97% to $88033.0 in 2024, then jumped by 58.3% to $139360.0 in 2025, then soared by 52.06% to $211911.0 in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $211911.0, $139360.0, and $287688.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 1.01 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 2.17 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 107.70 Mn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 668.96 Mn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 262.30 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 138.80 Mn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 164.45 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 40.22 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 158.04 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | 21,237.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21,237.00 |
| Mar 31, 2026 | 211,911.00 |
| Dec 31, 2025 | 139,360.00 |
| Sep 30, 2025 | 287,688.00 |
| Jun 30, 2025 | 111,872.00 |
| Mar 31, 2025 | 24,142.00 |
| Dec 31, 2024 | 88,033.00 |
| Sep 30, 2024 | 90.00 |
| Jun 30, 2024 | 8,365.00 |
| Mar 31, 2024 | 101,080.00 |
| Dec 31, 2023 | 65,222.00 |
| Sep 30, 2023 | 156,409.00 |
| Jun 30, 2023 | 197,304.00 |
| Mar 31, 2023 | 203,687.00 |
| Dec 31, 2022 | 68,615.00 |
| Sep 30, 2022 | 63,529.00 |
| Jun 30, 2022 | 111,461.00 |
| Mar 31, 2022 | 213,166.00 |
| Dec 31, 2021 | 85,838.00 |
| Sep 30, 2021 | 745,457.00 |